These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 3047043)
21. Evaluation of a monoclonal antibody to ras peptide, RAP-5, claimed to bind preferentially to cells of infiltrating carcinomas. Robinson A; Williams AR; Piris J; Spandidos DA; Wyllie AH Br J Cancer; 1986 Dec; 54(6):877-83. PubMed ID: 3542007 [TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical detection of ras p21 and c-myc p62 in colonic adenomas and carcinomas. Agnantis NJ; Apostolikas N; Sficas C; Zolota V; Spandidos DA Hepatogastroenterology; 1991 Jun; 38(3):239-42. PubMed ID: 1937363 [TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent nonneoplastic mucosa. Visca P; Alò PL; Del Nonno F; Botti C; Trombetta G; Marandino F; Filippi S; Di Tondo U; Donnorso RP Clin Cancer Res; 1999 Dec; 5(12):4111-8. PubMed ID: 10632348 [TBL] [Abstract][Full Text] [Related]
24. Relationship between ras oncogene expression and clinical and pathological features of colonic carcinoma. Michelassi F; Grad G; Erroi F; Roncella M; Romagnoli J; Handcock M Hepatogastroenterology; 1990 Oct; 37(5):513-6. PubMed ID: 2253930 [TBL] [Abstract][Full Text] [Related]
25. Expression of the 21,000 molecular weight ras protein in a spectrum of benign and malignant human mammary tissues. Ohuchi N; Thor A; Page DL; Hand PH; Halter SA; Schlom J Cancer Res; 1986 May; 46(5):2511-9. PubMed ID: 3084069 [TBL] [Abstract][Full Text] [Related]
26. [Immunohistochemical studies of ras oncogene product p21 in human ovarian tumors]. Yaginuma Y; Yamashita K Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1409-16. PubMed ID: 2685141 [TBL] [Abstract][Full Text] [Related]
27. Histologic demonstration of antigens reactive with anti-p21 ras monoclonal antibody (RAP-5) in human stomach cancers. Noguchi M; Hirohashi S; Shimosato Y; Thor A; Schlom J; Tsunokawa Y; Terada M; Sugimura T J Natl Cancer Inst; 1986 Aug; 77(2):379-85. PubMed ID: 3525957 [TBL] [Abstract][Full Text] [Related]
28. Expression of EGF, EGF-receptor, p53, v-erb B and ras p21 in colorectal neoplasms by immunostaining paraffin-embedded tissues. Hayashi Y; Widjono YW; Ohta K; Hanioka K; Obayashi C; Itoh K; Imai Y; Itoh H Pathol Int; 1994 Feb; 44(2):124-30. PubMed ID: 7912978 [TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical analysis of the ras oncogene protein product in human thyroid neoplasms. Papadimitriou K; Yiagnisis M; Tolis G; Spandidos DA Anticancer Res; 1988; 8(6):1223-7. PubMed ID: 3064713 [TBL] [Abstract][Full Text] [Related]
30. bcl-2 oncoprotein in colorectal hyperplastic polyps, adenomas, and adenocarcinomas. Bosari S; Moneghini L; Graziani D; Lee AK; Murray JJ; Coggi G; Viale G Hum Pathol; 1995 May; 26(5):534-40. PubMed ID: 7750937 [TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical study of oncogene product ras p21, c-myc and growth factor EGF in breast carcinomas. Mizukami Y; Nonomura A; Noguchi M; Taniya T; Koyasaki N; Saito Y; Hashimoto T; Matsubara F; Yanaihara N Anticancer Res; 1991; 11(4):1485-94. PubMed ID: 1660689 [TBL] [Abstract][Full Text] [Related]
32. Monoclonal antibodies define differential ras gene expression in malignant and benign colonic diseases. Thor A; Horan Hand P; Wunderlich D; Caruso A; Muraro R; Schlom J Nature; 1984 Oct 11-17; 311(5986):562-5. PubMed ID: 6482968 [TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical study of epithelial cell proliferation in hyperplastic polyps, adenomas, and adenocarcinomas of the large bowel. Risio M; Coverlizza S; Ferrari A; Candelaresi GL; Rossini FP Gastroenterology; 1988 Apr; 94(4):899-906. PubMed ID: 3345890 [TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical detection of RAS, JUN, FOS, and p53 oncoprotein expression in human colorectal adenomas and carcinomas. Magrisso IJ; Richmond RE; Carter JH; Pross CB; Gilfillen RA; Carter HW Lab Invest; 1993 Dec; 69(6):674-81. PubMed ID: 8264230 [TBL] [Abstract][Full Text] [Related]
35. Immunolocalization of ras oncogene p21 in human liver diseases. Radosevich JA; Gould KA; Koukoulis GK; Haines GK; Rosen ST; Lee I; Gould VE Ultrastruct Pathol; 1993; 17(1):1-8. PubMed ID: 8381245 [TBL] [Abstract][Full Text] [Related]
36. DNA content and the adenoma-carcinoma sequence in the colorectum. Goh HS; Jass JR J Clin Pathol; 1986 Apr; 39(4):387-92. PubMed ID: 3700672 [TBL] [Abstract][Full Text] [Related]
37. Monoclonal antibodies of predefined specificity detect activated ras gene expression in human mammary and colon carcinomas. Hand PH; Thor A; Wunderlich D; Muraro R; Caruso A; Schlom J Proc Natl Acad Sci U S A; 1984 Aug; 81(16):5227-31. PubMed ID: 6382261 [TBL] [Abstract][Full Text] [Related]
38. Differential expression of difucosyl type 2 chain (LeY) defined by monoclonal antibody AH6 in different locations of colonic epithelia, various histological types of colonic polyps, and adenocarcinomas. Abe K; Hakomori S; Ohshiba S Cancer Res; 1986 May; 46(5):2639-44. PubMed ID: 3516384 [TBL] [Abstract][Full Text] [Related]
39. Reported binding of monoclonal antibody RAP-5 to formalin-fixed tissue sections is not indicative of ras p21 expression. Samowitz WS; Paull G; Hamilton SR Hum Pathol; 1988 Feb; 19(2):127-32. PubMed ID: 2449385 [TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical analysis of normal and mutated ras oncogene p21 expression in human pulmonary and pleural neoplasms. Radosevich JA; Gould VE; Ma Y; Lee I; Thor A; Carney WP; Warren WH; Schlom J; Rosen ST Virchows Arch B Cell Pathol Incl Mol Pathol; 1989; 56(6):377-83. PubMed ID: 2567085 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]